Knowledge Center

Article / Aug 30, 2016

Accelerating approval and reducing costs of spray dried drugs through development by design

Authors:
  • Filipe Gaspar
  • Marcio Temtem
Source:
Pharma's Almanac, Global Pharmaceutical Supply Chain Trends, Q3 2016

Contract development and manufacturing organizations with unique technical capabilities and expertise are able to speed up the development and commercialization of novel medicines. Effective application of its extensive knowledge, data base and Development by Design approach has enabled Hovione to accelerate spray drying development, simultaneously reducing cost and time to get challenging drugs to patients in need.

Related links

Read article here

Also in the Knowledge Center

Related Content

Continuous Tableting for Drug Product

Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.

Page
Read more

High value applications

Hovione provides off-patent APIs that can be used with confidence where the choice of active ingredient is critical.

Page
Read more

Devices

Hovione offers simple, patented and globally competitive dry powder inhalers – Disposable, Capsule, Blister and Large Dose DPIs – which are available for fully integrated turn-key development with formulation and for licensing.

Page
Read more